Lung cancer : journal of the International Association for the Study of Lung Cancer

01 20 October 2026

DOI 10.1016/j.lungcan.2026.109646

Severe hepatic injury or immune-related hepatitis? Reconsidering the hepatic safety signal in HBsAg-positive lung cancer

Open DOI

Luyun Li, Gang Tian

02 19 October 2026

DOI 10.1016/j.lungcan.2026.109669

Integrated histopathological, immunohistochemical, and molecular profiling reveals hidden heterogeneity within histologic subtypes of thymoma

Open DOI

Yi-Chen Yeh, Min-Shu Hsieh, Lei-Chi Wang et al.

03 19 October 2026

DOI 10.1016/j.lungcan.2026.109671

Efficacy and safety of primary granulocyte colony-stimulating factor prophylaxis in patients with small-cell lung cancer receiving first-line platinum–etoposide plus a programmed death-ligand 1 inhibitor: A multicenter retrospective observational study

Open DOI

Shuhei Teranishi, Yuki Misumi, Takuma Ishihara et al.

04 18 October 2026

DOI 10.1016/j.lungcan.2026.109668

Phase I and early phase II study of enhancing immune checkpoint inhibitor efficacy using a Mycobacterium tuberculosis extract combined with radiation therapy in non-small cell lung cancer patients: NEJ046A

Open DOI

Atsuto Mouri, Jun Sugisaka, Yu Miura et al.

05 17 October 2026

DOI 10.1016/j.lungcan.2026.109667

Multi-omics liquid biopsy for leptomeningeal metastases in lung cancer: from molecular mechanisms to precision diagnosis and treatment

Open DOI

Ruilong Zhang, Qi Zhao, Yue Cao et al.

06 15 October 2026

DOI 10.1016/s0169-5002(26)00719-1

Contents

Open DOI

07 14 October 2026

DOI 10.1016/j.lungcan.2026.109663

From whole-exome sequencing to functional insight: Characterization of rare germline variants in lung cancer

Open DOI

Simone Bonora, Maron Daw, Claudio Tabolacci et al.

08 14 October 2026

DOI 10.1016/j.lungcan.2026.109650

Exosomal miR-3662 originating from M2-polarized macrophages facilitates cisplatin resistance of lung adenocarcinoma cells through inhibiting the IRF8/RASSF5 cascade and boosting autophagy

Open DOI

Fengqiang Yu, Jiazhou Xiao, Nanlong Lin et al.

09 13 October 2026

DOI 10.1016/j.lungcan.2026.109644

Real-world effectiveness and safety of lurbinectedin in previously treated small cell lung cancer: results from Jazz EMERGE 402

Open DOI

Firas B. Badin, Philip E. Lammers, Geoffrey Liu et al.

10 9 October 2026

DOI 10.1016/j.lungcan.2026.109649

Efficacy and safety of adjuvant ensartinib in stage I ALK-positive NSCLC patients: a retrospective, multicenter study

Open DOI

Ziyan Gao, Jian Zheng, Linlin Jia et al.